Boston Scientific (NYSE:BSX) Price Target Raised to $125.00
Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Barclays from $118.00 to $125.00 in a research report report published on Friday,Benzinga reports. The firm currently has an overweight rating on the medical equipment provider’s stock. A number of other equities research analysts also recently weighed in on the company. Royal Bank […]
Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Barclays from $118.00 to $125.00 in a research report report published on Friday,Benzinga reports. The firm currently has an overweight rating on the medical equipment provider’s stock. A number of other equities research analysts also recently weighed in on the company. Royal Bank […]
